{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:16:48Z","timestamp":1771327008908,"version":"3.50.1"},"reference-count":23,"publisher":"Baishideng Publishing Group Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGPT"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4292\/wjgpt.v1.i5.102","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T20:27:01Z","timestamp":1288124821000},"page":"102","source":"Crossref","is-referenced-by-count":10,"title":["Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?"],"prefix":"10.4292","volume":"1","author":[{"given":"Joanna Dulce Favacho de Oliveira","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti EM. Melatonin in plants. Adv Exp Med Biol 2003;527:593-597.","DOI":"10.1007\/978-1-4615-0135-0_68"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ. Phytomelatonin: a review. J Exp Bot 2009;60:57-69.","DOI":"10.1093\/jxb\/ern284"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Altun A, Ugur-Altun B. Melatonin: therapeutic and clinical utilization. Int J Clin Pract 2007;61:835-845.","DOI":"10.1111\/j.1742-1241.2006.01191.x"},{"key":"ref4","unstructured":"Werbach MR. Melatonin for the treatment of gastroesophageal reflux disease. Altern Ther Health Med 2008;14:54-58."},{"key":"ref5","unstructured":"Kalant H. Roschlau WHE Principles of Medical Pharmacology. 6th edition New York: Oxford University Press; 1998;558."},{"key":"ref6","unstructured":"Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol 2007;58 Suppl 6:97-103."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bubenik GA, Ayles HL, Friendship RM, Brown GM, Ball RO. Relationship between melatonin levels in plasma and gastrointestinal tissues and the incidence and severity of gastric ulcers in pigs. J Pineal Res 1998;24:62-66.","DOI":"10.1111\/j.1600-079X.1998.tb00367.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"de Souza Pereira R. Regression of an esophageal ulcer using a dietary supplement containing melatonin. J Pineal Res 2006;40:355-356.","DOI":"10.1111\/j.1600-079X.2006.00324.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Pereira Rde S. Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole. J Pineal Res 2006;41:195-200.","DOI":"10.1111\/j.1600-079X.2006.00359.x"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease. BMC Gastroenterol 2010;10:7.","DOI":"10.1186\/1471-230X-10-7"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Cooper BT, Chapman W, Neumann CS, Gearty JC. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006;23:727-733.","DOI":"10.1111\/j.1365-2036.2006.02825.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Konturek PC, Konturek SJ, Hahn EG. Duodenal alkaline secretion: its mechanisms and role in mucosal protection against gastric acid. Dig Liver Dis 2004;36:505-512.","DOI":"10.1016\/j.dld.2004.03.008"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Jaworek J, Brzozowski T, Konturek SJ. Melatonin as an organoprotector in the stomach and the pancreas. J Pineal Res 2005;38:73-83.","DOI":"10.1111\/j.1600-079X.2004.00179.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Holloway RH. Systemic pharmacomodulation of transient lower esophageal sphincter relaxations. Am J Med 2001;111 Suppl 8A:178S-185S.","DOI":"10.1016\/S0002-9343(01)00853-1"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Viste A, Øvrebø K, Maartmann-Moe H, Waldum H. Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer 2004;7:31-35.","DOI":"10.1007\/s10120-003-0264-1"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Vermeer IT, Engels LG, Pachen DM, Dallinga JW, Kleinjans JC, van Maanen JM. Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole. Gastroenterology 2001;121:517-525.","DOI":"10.1053\/gast.2001.27098"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004;171:33-38.","DOI":"10.1503\/cmaj.1040876"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Turco R, Martinelli M, Miele E, Roscetto E, Del Pezzo M, Greco L, Staiano A. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010;31:754-759.","DOI":"10.1111\/j.1365-2036.2009.04229.x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009;137:80-87, 87.e1.","DOI":"10.1053\/j.gastro.2009.03.058"},{"key":"ref20","unstructured":"Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Marshall RD, Nemeroff CB, Shalev AY, Yehuda R. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 2004;65 Suppl 1:55-62."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hood SD, Hince DA, Davies SJ, Argyropoulos S, Robinson H, Potokar J, Nutt DJ. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder. Psychopharmacology (Berl) 2010;208:223-232.","DOI":"10.1007\/s00213-009-1722-1"},{"key":"ref22","unstructured":"Vasterling JJ, Brewin CR. Neuropsychology of PTSD: Biological, cognitive, and clinical perspectives New York: Guilford Press; 2005;27."},{"key":"ref23","unstructured":"Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Mason JW, Heninger GR, Price LH. Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. J Clin Endocrinol Metab 1993;76:1160-1164."}],"container-title":["World Journal of Gastrointestinal Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T18:32:48Z","timestamp":1559759568000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2150-5349\/full\/v1\/i5\/102.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.4292\/wjgpt.v1.i5.102","relation":{},"ISSN":["2150-5349"],"issn-type":[{"value":"2150-5349","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}